Publications by authors named "Catherine Carson"

A variety of U.S. Food and Drug Administration-approved hormone therapy options are currently used to successfully alleviate unwanted symptoms associated with the changing endogenous hormonal milieu that occurs in midlife with menopause.

View Article and Find Full Text PDF

Hormone therapy that contains 17β-estradiol (E2) is used commonly for treatment of symptoms associated with menopause. E2 treatment has been shown to improve cognitive function following the decrease in ovarian hormones that is characteristic of menopause. However, once in circulation, the majority of E2 is bound to serum hormone binding globulin or albumin, becoming biologically inactive.

View Article and Find Full Text PDF

Cognitive changes that occur during mid-life and beyond are linked to both aging and the menopause transition. Studies in women suggest that the age at menopause onset can impact cognitive status later in life; yet, little is known about memory changes that occur during the transitional period to the postmenopausal state. The 4-vinylcyclohexene diepoxide (VCD) model simulates transitional menopause in rodents by depleting the immature ovarian follicle reserve and allowing animals to retain their follicle-deplete ovarian tissue, resulting in a profile similar to the majority of perimenopausal women.

View Article and Find Full Text PDF

A field trial was conducted for a portable Knee Height Measuring Device (KHMD). Measurement errors for the machine, within and between observers (intraobserver and interobserver) and within subjects (intrasubject), were calculated from repeated observations of two anthropometrists on 40 children, 8 and 9 years of age. Interobserver technical error (0.

View Article and Find Full Text PDF